Articles

Erin Michos, MD: Sex Specific Differences in Risk Factor Profiles in Diabetes Care

At HiD 2022, Dr. Budoff discusses the use and utility of coronary calcium scoring for risk stratification 

Matthew Budoff, MD: The Clinical Utility of Coronary Calcium Scoring 

Videos

Dr. Martin explores the explosion of new consumer technologies and how to close the gap in disparities between data collection and using the data in practice. 

Seth Martin, MD: Translating Evidence From Digital Health Innovations 

Dr. Ray discusses the impact of current practice on cholesterol goal attainment and what more needs to be done. 

Kausik Ray, MD: A Risk-Based Look at LDL Cholesterol Lowering

Dr. Green discusses the potential of combination therapy to reduce cardiovascular and kidney outcomes in people with type 2 diabetes.

Jennifer Green, MD: Outcomes, Impact of SGLT2i, GLP-1 RA Combination Therapy 

Dr. Joseph discusses modalities to address cardiometabolic disease in individuals around the country, from lifestyle management to policy-level changes. 

Joshua J. Joseph, MD: Managing CV Risk Factors in Patients with Type 2 Diabetes

Fish oil intervention and DASH diet show no statistically significant effect on
glycemic control and adiposity. 

Fish Oil, DASH Diet Partially Alters Lipid Metabolism in Patients with Type 2 Diabetes

Data show the relative expression of SORT1 gene was upregulated by 4.438 fold in patients with CAD, compared to control.

Sortilin 1 Gene Shows Positive Association with Coronary Artery Disease 

Data show all 7 studies using relative risk found an association between metabolic syndrome and the development of PAD, but one study (RR: 1.31). 

Inconsistencies Observed in Defining Metabolic Syndrome As Risk Factor for PAD 

Data show cfPWV at 17.7 years was independently and directly associated with total fat mass and trunk fat mass at 24.5 years. 

The Metabolic Institute of America

Latest News